SRF announces $130k collaborative grant to the Tang Lab @BostonChildrens & @Axonis_US to see if a #KCC2 enhancing drug will ameliorate #SYNGAP1.
Also quoted: @SVH_neuro, @KadamLab & @JMGraglia.
This is possible due to the generosity of our families.
https://t.co/CmdNY3gDsP
ATTN Rare Disease Peeps: I have some amazing news!!!! Our amazing friends at @H4B have offered to sponsor this program. Our BTD kids will be on a Jumbotron in Times Square for the ENTIRE MONTH of February, running most of the day!!!!! #RareInTimesSquare#RareDiseaseDay
Chat GPT does it again... #ionchannels
Oh sodium channels, so small and discrete
Yet your role in our nerves, oh how complete
You open and close with such precise control
Allowing impulses to flow, like a river on a roll
(1/2)
@IngoHelbig ending on the topic of Natural History Studies...
Starting with #STXBP1 and expanding to #SYNGAP1, #CHD2, #SCN8A, and others in the near future.
Join us on 2/2 (also our International CHD2 Awareness Day), for a presentation by Dr. Ingo Helbig from CHOP. He will share some findings from our CHD2 digital natural history study with Ciitizen/Invitae. @IngoHelbig
Register here: https://t.co/BKzTbOKNea
Thank you @DNATodayPodcast for helping us to raise #SYNGAP1 🧬 awareness to the critical audience of #GeneticCounselors with our very own SAB-level GC @IDreamofGenes & our co-founder @JMGraglia. With so many patients still to find and GCs are critical!
https://t.co/lj2fRmIWvF
Infantile spasms most often occur between 4 and 6 months of age but can begin anytime in the first 2 years. Know the signs to look for in your baby: https://t.co/X5r9fIgc2D #ISAW2022#epilepsy#seizures#EpilepsyAwareness
What a treat to hear @julietkknowles describe her discovery of generalized epilepsy-associated maladaptive myelination. This work was reported earlier this year in Nature Neuroscience 🧠. #AES2022
Exquisite science from @shridparth and @IngoHelbig identifies a recurrent #DNM1 variant in the non-canonical transcript, with implications for clinical genetic testing and reporting. Another highly impactful collaboration between researchers and families.
Who knew the hottest spot in town was the #DEE SIG meeting! Although I’m sad I can’t get in, happy to know #RareEpilepsies are attracting broader audiences #AES2022
What a privilege to hear from @JMGraglia representing @cureSYNGAP1 at #AES2022. Patient advocacy groups are powerful allies in #Rare research and drug development. It’s an honour to know you, friend!